Global Leading Market Research Publisher QYResearch announces the release of its latest report “Size Exclusion Chromatography – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Size Exclusion Chromatography market, including market size, share, demand, industry development status, and forecasts for the next few years.
For biopharmaceutical researchers, quality control scientists, and polymer chemists, the ability to separate and characterize molecules by size is fundamental to ensuring product purity, consistency, and safety. Size exclusion chromatography (SEC) provides this essential capability—a gentle, non-destructive method that separates proteins, polysaccharides, polymers, and other macromolecules based on their hydrodynamic volume. As the biopharmaceutical industry continues to expand, with biologic drugs representing an increasing share of new drug approvals, and as polymer science advances across materials applications, the demand for reliable SEC solutions is accelerating. This report delivers comprehensive market intelligence for stakeholders navigating this critical segment of the analytical and preparative chromatography market.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6090919/size-exclusion-chromatography
Market Scale and Growth Trajectory
The global market for Size Exclusion Chromatography was estimated to be worth US$ 335 million in 2025 and is projected to reach US$ 607 million, growing at a CAGR of 9.0% from 2026 to 2032. This robust growth reflects the convergence of several powerful drivers: the exponential growth of the biopharmaceutical industry and its reliance on SEC for protein characterization, the increasing complexity of biologic drugs requiring advanced analytical methods, and the expanding applications of SEC in polymer science, food analysis, and academic research. According to QYResearch data, the market’s strong growth trajectory is further supported by continuous innovation in column technology, improved resin chemistries, and the integration of SEC with advanced detection systems.
Key Market Trends Driving Growth:
- Biopharmaceutical Expansion: The global biologics market, exceeding $400 billion, drives demand for SEC in protein purification and characterization
- Biosimilar Development: Increasing biosimilar development requires comprehensive comparability studies where SEC is essential
- Quality by Design (QbD): Regulatory emphasis on product characterization drives adoption of robust analytical methods
- Novel Modalities: Development of antibody-drug conjugates (ADCs), gene therapies, and cell therapies requires advanced SEC capabilities
- Polymers and Materials: Expanding applications in polymer characterization, nanotechnology, and materials science
Understanding Size Exclusion Chromatography: Principles, Technology, and Applications
Size exclusion chromatography is a chromatographic method that separates molecules based on their size. This method uses a chromatographic column filled with a porous medium. Large molecules cannot enter the small pores and elute earlier, while small molecules enter the pores and stay longer, thus achieving separation. SEC is widely used in molecular weight determination, purification and homogeneity analysis of samples such as proteins, polysaccharides and polymers.
Separation Principle:
SEC operates on the principle of molecular exclusion rather than chemical interaction. The stationary phase consists of porous particles with a defined pore size distribution. As the mobile phase carries the sample through the column:
- Large Molecules: Excluded from pores, travel through the interstitial space, and elute first
- Intermediate Molecules: Partially enter pores, resulting in intermediate retention times
- Small Molecules: Fully penetrate the pore structure, eluting last
This size-based separation mechanism offers several distinct advantages:
- Non-Destructive: Gentle separation without interaction with the stationary phase preserves sample integrity
- Predictable: Elution order is directly related to molecular size
- Versatile: Applicable to a wide range of molecule types across varying conditions
Key Resin Types:
- Dextran-based: Cross-linked dextran polymers (e.g., Sephadex) offering excellent hydrophilicity and wide molecular weight range. Ideal for peptide and protein separations under native conditions.
- Agarose-based: Highly porous, hydrophilic matrices (e.g., Sepharose, Superose) providing superior resolution for large biomolecules, including antibodies, viruses, and protein complexes.
- Polyacrylamide-based: Synthetic polymer resins (e.g., Bio-Gel P) offering excellent chemical stability and defined pore structures, used for a wide range of biomolecule separations.
- Others: Including silica-based and mixed-mode resins for specialized applications.
Key Applications:
- Biopharmaceutical Industry: The largest and fastest-growing application segment, encompassing:
- Monoclonal Antibody Analysis: Aggregation and fragmentation characterization
- Protein Purification: Buffer exchange and desalting
- Formulation Development: Stability and aggregation studies
- Process Development: Optimization of purification steps
- Scientific Research & Academic Laboratories: A significant segment supporting fundamental research in biochemistry, molecular biology, and polymer science.
- Others: Including food analysis, environmental testing, and industrial polymer characterization.
Industry Development Characteristics: Market Segmentation and Competitive Landscape
Market Segmentation by Resin Type
- Agarose-based: The largest segment, driven by biopharmaceutical applications requiring high-resolution separation of large biomolecules. Agarose resins offer excellent biocompatibility and broad molecular weight range.
- Dextran-based: A significant segment serving peptide and small protein applications where hydrophilic matrices are essential.
- Polyacrylamide-based: A specialized segment offering defined pore structures and chemical stability for diverse applications.
- Others: Including silica-based resins for high-pressure applications and emerging resin technologies.
Competitive Landscape
The size exclusion chromatography market features established leaders in life science tools and specialized chromatography suppliers:
- Global Leaders: Cytiva (formerly GE Healthcare Life Sciences), Bio-Rad Laboratories, Merck (MilliporeSigma), Tosoh Bioscience, Thermo Fisher Scientific, Agilent Technologies
- Specialized Suppliers: Sartorius Stedim Biotech, Repligen Corporation, Purolite Life Sciences, Avantor, Bio-Works Technologies AB, Phenomenex
- Asian Leaders: Yeasen, Changzhou smart-Lifesciences Biotechnology Co., Ltd., Bioeast
Industry Trends: The Biopharmaceutical Imperative
Monoclonal Antibodies and SEC Characterization
A defining characteristic of current market development is the critical role of SEC in monoclonal antibody (mAb) development and manufacturing. mAbs, representing the largest segment of the biologics market, require rigorous characterization of:
- Aggregation: High molecular weight species (aggregates) can impact safety and efficacy
- Fragmentation: Low molecular weight species (fragments) may indicate instability
- Purity: Removal of process-related impurities
SEC has become the standard method for aggregation analysis in mAb release testing, with regulatory guidance specifying SEC for aggregate quantitation. According to industry data, the typical mAb manufacturing process includes SEC analysis at multiple stages: cell culture harvest, purification intermediates, final drug substance, and stability studies.
A recent case study from a major biopharmaceutical company illustrates the importance of SEC in biologics development. The company was developing a novel bispecific antibody with complex aggregation behavior. Using high-resolution SEC columns with advanced detection (multi-angle light scattering, MALS), the analytical team was able to:
- Characterize Aggregates: Identify and quantify multiple aggregate species
- Optimize Formulation: Screen excipients to minimize aggregation
- Establish Stability: Demonstrate product stability across intended shelf life
- Regulatory Approval: Provide comprehensive characterization data supporting regulatory submission
Biosimilar Comparability Studies
The biosimilar market has created additional demand for SEC. Biosimilar developers must demonstrate that their product is highly similar to the reference biologic. SEC, combined with orthogonal methods, provides essential comparability data on aggregation profiles, fragmentation patterns, and molecular weight distribution.
Exclusive Analyst Observation: The Move Toward High-Throughput SEC
Our ongoing market monitoring reveals that the biopharmaceutical industry is increasingly adopting high-throughput SEC methods to accelerate development timelines. Traditional SEC runs require 20-40 minutes per sample. Advances in column technology and UHPLC-compatible SEC resins have enabled:
- Rapid Analysis: Separation times reduced to 5-10 minutes
- Smaller Sample Volumes: Compatibility with low-volume samples from early development
- Automation: Integration with liquid handlers for unattended operation
These advances enable higher sample throughput, accelerating process development and quality control testing. Manufacturers offering high-throughput SEC solutions capture premium positioning in the market.
Technical Challenges and Policy Drivers
Technical Hurdles: Despite its established role, SEC faces several technical challenges:
- Resolution: Separating closely related species (e.g., monomer from dimer) requires optimized column and method conditions
- Compatibility: SEC resins must be compatible with a wide range of mobile phases and sample matrices
- Stability: Resin stability under cleaning-in-place (CIP) conditions is essential for manufacturing applications
Regulatory Landscape: SEC methods for biopharmaceutical analysis are subject to regulatory expectations. The International Council for Harmonisation (ICH) Q6B specifies testing requirements for biotech products, including molecular weight and purity determinations where SEC is often the method of choice. Method validation according to ICH Q2(R1) is required for release testing.
Strategic Implications for Industry Participants
For biopharmaceutical manufacturers, analytical scientists, and laboratory suppliers, several considerations emerge from current market dynamics:
Method Development Expertise: Successful SEC method development requires understanding of column selection, mobile phase optimization, and detection options. Collaboration with column suppliers with application expertise accelerates development.
Regulatory Compliance: For quality control applications, SEC methods must be fully validated according to regulatory guidance. Suppliers offering validated methods and regulatory support provide significant customer value.
Integration with Advanced Detection: SEC combined with advanced detectors—multi-angle light scattering (MALS), dynamic light scattering (DLS), and mass spectrometry—provides deeper characterization. Systems offering integrated detection solutions capture premium market segments.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
